In vitro prevention by ACE inhibitors of cataract induced by glucose

Objectives: To study, the anticataract activity of lisinopril and enalapril on cataract induced by glucose, in goat lenses. Materials and Methods: Goat lenses were incubated in artificial aqueous humor containing 55 mM glucose (cataractogenesis) with lisinopril or enalapril in different concentratio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Indian journal of pharmacology 2006-03, Vol.38 (2), p.107
Hauptverfasser: Langade, Deepak, Rao, G, Girme, R, Patki, P, Bulakh, P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page 107
container_title Indian journal of pharmacology
container_volume 38
creator Langade, Deepak
Rao, G
Girme, R
Patki, P
Bulakh, P
description Objectives: To study, the anticataract activity of lisinopril and enalapril on cataract induced by glucose, in goat lenses. Materials and Methods: Goat lenses were incubated in artificial aqueous humor containing 55 mM glucose (cataractogenesis) with lisinopril or enalapril in different concentrations at room temperature for 72 h. Biochemical parameters studied in the lens were electrolytes (Na+, K+), Na+-K+-ATPase activity, malondialdehyde (MDA) and proteins. Results: Glucose induced opacification of goat lens began 8-10 hrs after incubation and was complete in 72-80 hrs. Cataractous lenses showed higher Na+, MDA (P< 0.001), lower Na+-K+-ATPase activity, and water-soluble protein content. Lenses treated with lisinopril or enalapril in concentrations of 1, 5, and 10 ng/ml showed higher protein (total and water soluble proteins) content and prevented formation and progress of cataract by glucose, as evidenced by biochemical parameters. Conclusion: The anticataract activity of lisinopril and enalapril may be because of the antioxidant and free radical scavenging activity, as evidenced by a decrease in MDA in treated lenses. Further in-vitro and in-vivo studies in various experimental models and long term clinical trials are required to validate the anticataract activity of ACE-inhibitors.
doi_str_mv 10.4103/0253-7613.24615
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_195855045</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A145048876</galeid><sourcerecordid>A145048876</sourcerecordid><originalsourceid>FETCH-LOGICAL-c260t-34d126cc25f5ce36846a47fe44ff8c0cc0ad44a5943a7043384059f76d3511ee3</originalsourceid><addsrcrecordid>eNptkU1PAjEQhhujiYievW68L7Tbj909EkQlIfGi56Z0p1iytNgWEv69XTGeyBwm884zH5lB6JHgCSOYTnHFaVkLQicVE4RfoRFp26akNSfXaPSfvUV3MW5xjlkrRuh56YqjTcEX-wBHcMl6V6xPxWy-KKz7smubfIiFN4VWSQWlU5a7g4ZuoDb9QfsI9-jGqD7Cw58fo8-Xxcf8rVy9vy7ns1WpK4FTSVlHKqF1xQ3XQEXDhGK1AcaMaTTWGquOMcVbRlWNGaUNw7w1tegoJwSAjtHTue8--O8DxCS3_hBcHilJyxvOMeMZKs_QRvUgrTM-5bU34CCo3jswNsszwjLcNLXI_OQCn62DndUXC6bnAh18jAGM3Ae7U-EkCZbDK-RwbDkcW_6-gv4AMIF5Fw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195855045</pqid></control><display><type>article</type><title>In vitro prevention by ACE inhibitors of cataract induced by glucose</title><source>Bioline International</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Langade, Deepak ; Rao, G ; Girme, R ; Patki, P ; Bulakh, P</creator><creatorcontrib>Langade, Deepak ; Rao, G ; Girme, R ; Patki, P ; Bulakh, P</creatorcontrib><description>Objectives: To study, the anticataract activity of lisinopril and enalapril on cataract induced by glucose, in goat lenses. Materials and Methods: Goat lenses were incubated in artificial aqueous humor containing 55 mM glucose (cataractogenesis) with lisinopril or enalapril in different concentrations at room temperature for 72 h. Biochemical parameters studied in the lens were electrolytes (Na+, K+), Na+-K+-ATPase activity, malondialdehyde (MDA) and proteins. Results: Glucose induced opacification of goat lens began 8-10 hrs after incubation and was complete in 72-80 hrs. Cataractous lenses showed higher Na+, MDA (P&lt; 0.001), lower Na+-K+-ATPase activity, and water-soluble protein content. Lenses treated with lisinopril or enalapril in concentrations of 1, 5, and 10 ng/ml showed higher protein (total and water soluble proteins) content and prevented formation and progress of cataract by glucose, as evidenced by biochemical parameters. Conclusion: The anticataract activity of lisinopril and enalapril may be because of the antioxidant and free radical scavenging activity, as evidenced by a decrease in MDA in treated lenses. Further in-vitro and in-vivo studies in various experimental models and long term clinical trials are required to validate the anticataract activity of ACE-inhibitors.</description><identifier>ISSN: 0253-7613</identifier><identifier>EISSN: 1998-3751</identifier><identifier>DOI: 10.4103/0253-7613.24615</identifier><language>eng</language><publisher>Pondicherry: Medknow Publications and Media Pvt. Ltd</publisher><subject>ACE inhibitors ; Cataract ; Dextrose ; Glucose ; Lisinopril ; Surgery</subject><ispartof>Indian journal of pharmacology, 2006-03, Vol.38 (2), p.107</ispartof><rights>COPYRIGHT 2006 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications Mar/Apr 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c260t-34d126cc25f5ce36846a47fe44ff8c0cc0ad44a5943a7043384059f76d3511ee3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Langade, Deepak</creatorcontrib><creatorcontrib>Rao, G</creatorcontrib><creatorcontrib>Girme, R</creatorcontrib><creatorcontrib>Patki, P</creatorcontrib><creatorcontrib>Bulakh, P</creatorcontrib><title>In vitro prevention by ACE inhibitors of cataract induced by glucose</title><title>Indian journal of pharmacology</title><description>Objectives: To study, the anticataract activity of lisinopril and enalapril on cataract induced by glucose, in goat lenses. Materials and Methods: Goat lenses were incubated in artificial aqueous humor containing 55 mM glucose (cataractogenesis) with lisinopril or enalapril in different concentrations at room temperature for 72 h. Biochemical parameters studied in the lens were electrolytes (Na+, K+), Na+-K+-ATPase activity, malondialdehyde (MDA) and proteins. Results: Glucose induced opacification of goat lens began 8-10 hrs after incubation and was complete in 72-80 hrs. Cataractous lenses showed higher Na+, MDA (P&lt; 0.001), lower Na+-K+-ATPase activity, and water-soluble protein content. Lenses treated with lisinopril or enalapril in concentrations of 1, 5, and 10 ng/ml showed higher protein (total and water soluble proteins) content and prevented formation and progress of cataract by glucose, as evidenced by biochemical parameters. Conclusion: The anticataract activity of lisinopril and enalapril may be because of the antioxidant and free radical scavenging activity, as evidenced by a decrease in MDA in treated lenses. Further in-vitro and in-vivo studies in various experimental models and long term clinical trials are required to validate the anticataract activity of ACE-inhibitors.</description><subject>ACE inhibitors</subject><subject>Cataract</subject><subject>Dextrose</subject><subject>Glucose</subject><subject>Lisinopril</subject><subject>Surgery</subject><issn>0253-7613</issn><issn>1998-3751</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkU1PAjEQhhujiYievW68L7Tbj909EkQlIfGi56Z0p1iytNgWEv69XTGeyBwm884zH5lB6JHgCSOYTnHFaVkLQicVE4RfoRFp26akNSfXaPSfvUV3MW5xjlkrRuh56YqjTcEX-wBHcMl6V6xPxWy-KKz7smubfIiFN4VWSQWlU5a7g4ZuoDb9QfsI9-jGqD7Cw58fo8-Xxcf8rVy9vy7ns1WpK4FTSVlHKqF1xQ3XQEXDhGK1AcaMaTTWGquOMcVbRlWNGaUNw7w1tegoJwSAjtHTue8--O8DxCS3_hBcHilJyxvOMeMZKs_QRvUgrTM-5bU34CCo3jswNsszwjLcNLXI_OQCn62DndUXC6bnAh18jAGM3Ae7U-EkCZbDK-RwbDkcW_6-gv4AMIF5Fw</recordid><startdate>20060301</startdate><enddate>20060301</enddate><creator>Langade, Deepak</creator><creator>Rao, G</creator><creator>Girme, R</creator><creator>Patki, P</creator><creator>Bulakh, P</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20060301</creationdate><title>In vitro prevention by ACE inhibitors of cataract induced by glucose</title><author>Langade, Deepak ; Rao, G ; Girme, R ; Patki, P ; Bulakh, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c260t-34d126cc25f5ce36846a47fe44ff8c0cc0ad44a5943a7043384059f76d3511ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>ACE inhibitors</topic><topic>Cataract</topic><topic>Dextrose</topic><topic>Glucose</topic><topic>Lisinopril</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Langade, Deepak</creatorcontrib><creatorcontrib>Rao, G</creatorcontrib><creatorcontrib>Girme, R</creatorcontrib><creatorcontrib>Patki, P</creatorcontrib><creatorcontrib>Bulakh, P</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Indian journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Langade, Deepak</au><au>Rao, G</au><au>Girme, R</au><au>Patki, P</au><au>Bulakh, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro prevention by ACE inhibitors of cataract induced by glucose</atitle><jtitle>Indian journal of pharmacology</jtitle><date>2006-03-01</date><risdate>2006</risdate><volume>38</volume><issue>2</issue><spage>107</spage><pages>107-</pages><issn>0253-7613</issn><eissn>1998-3751</eissn><abstract>Objectives: To study, the anticataract activity of lisinopril and enalapril on cataract induced by glucose, in goat lenses. Materials and Methods: Goat lenses were incubated in artificial aqueous humor containing 55 mM glucose (cataractogenesis) with lisinopril or enalapril in different concentrations at room temperature for 72 h. Biochemical parameters studied in the lens were electrolytes (Na+, K+), Na+-K+-ATPase activity, malondialdehyde (MDA) and proteins. Results: Glucose induced opacification of goat lens began 8-10 hrs after incubation and was complete in 72-80 hrs. Cataractous lenses showed higher Na+, MDA (P&lt; 0.001), lower Na+-K+-ATPase activity, and water-soluble protein content. Lenses treated with lisinopril or enalapril in concentrations of 1, 5, and 10 ng/ml showed higher protein (total and water soluble proteins) content and prevented formation and progress of cataract by glucose, as evidenced by biochemical parameters. Conclusion: The anticataract activity of lisinopril and enalapril may be because of the antioxidant and free radical scavenging activity, as evidenced by a decrease in MDA in treated lenses. Further in-vitro and in-vivo studies in various experimental models and long term clinical trials are required to validate the anticataract activity of ACE-inhibitors.</abstract><cop>Pondicherry</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><doi>10.4103/0253-7613.24615</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0253-7613
ispartof Indian journal of pharmacology, 2006-03, Vol.38 (2), p.107
issn 0253-7613
1998-3751
language eng
recordid cdi_proquest_journals_195855045
source Bioline International; EZB-FREE-00999 freely available EZB journals; Free Full-Text Journals in Chemistry
subjects ACE inhibitors
Cataract
Dextrose
Glucose
Lisinopril
Surgery
title In vitro prevention by ACE inhibitors of cataract induced by glucose
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T16%3A53%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20prevention%20by%20ACE%20inhibitors%20of%20cataract%20induced%20by%20glucose&rft.jtitle=Indian%20journal%20of%20pharmacology&rft.au=Langade,%20Deepak&rft.date=2006-03-01&rft.volume=38&rft.issue=2&rft.spage=107&rft.pages=107-&rft.issn=0253-7613&rft.eissn=1998-3751&rft_id=info:doi/10.4103/0253-7613.24615&rft_dat=%3Cgale_proqu%3EA145048876%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=195855045&rft_id=info:pmid/&rft_galeid=A145048876&rfr_iscdi=true